Seòmar agus comataidhean

The Stoma Care Quality and Cost Effectiveness Review was undertaken by NHS Greater Glasgow and Clyde on behalf of NHS Scotland. The only cost incurred in producing the report was £858.40 for publishing the document. There were no costs incurred by Scottish Government for the National Stoma Quality Improvement Short Life Working Group.

While the Scottish Government provides the policies, frameworks and resources for high quality health care in Scotland, it is for each NHS board to decide how best to deliver those services to meet the needs of the population to ensure they can provide safe, effective care for their patients. It is for boards to decide which recommendations from the reports to prioritise to meet these objectives.

The Scottish Government has a number of legacy items manufactured by Hikvision which are being phased out as part of an on-going security improvement programme.

The additional funding to deliver the Communities Mental Health and Wellbeing Fund for Adults in 2021-22 has been identified as part of the £120 million Mental Health Recovery & Renewal (MH R&R) Fund to ensure the delivery of commitments set out in the Mental Health Transition and Recovery Plan.

The new Communities Mental Health and Wellbeing Fund for adults was launched in October 2021 with £15 million of funding from the Mental Health Recovery & Renewal budget. The Fund aims to support grassroots community-based initiatives across Scotland which promote good mental health and wellbeing and early intervention for those in distress and tackle the impact of social isolation, loneliness and the mental health inequalities made worse by the pandemic. The Fund is managed locally by Third Sector Interface (TSI) bodies and is designed to support the development of an integrated culture of mental wellbeing and prevention within local communities.

Following a very positive response to the Fund from communities across Scotland, the additional £6 million funding for 2021-22 announced in February has been provided to TSIs to meet the demand for local mental health and wellbeing projects, bringing total funding to £21 million in 2021-22.

No Hikvision cameras have been installed on the core Scottish Government estate since July 2021.

The Scottish Government does not hold this information. National Procurement Scotland are responsible for the service level agreement with stoma manufacturers.

Scottish Government does not centrally hold data for all hospital acquired infection deaths by Health Board, due to patient identifiable information.

2000 to 2020 data for registered deaths due to Clostridioides difficile infection and MRSA is available from National Records of Scotland (NRS) can be found here and here .

However, it should be noted that although publically available details also broken down by Health Board, the data does not make the distinction between hospital acquired or community acquired infection.

The Scottish Government does not hold this information and we would expect individual NHS Boards to consider and implement this funding locally.

The national procurement process responsibility is undertaken by NHS National Services Scotland for stoma care product suppliers and managing supplies to NHS Boards across Scotland.

I refer the member to the answer to earlier questions: S6W-06594, S6W-06595 on 1 March 2022.

Guidance will be included on vaccination appointment letters, signposting people to additional support should it be required. Additionally, if people need any additional support at their vaccine appointment, they can call the National Vaccination Helpline on 0800 030 8013 to discuss. Information on the COVID-19 vaccine is available in a range of different formats on NHS Inform , including in audio, easy read and large print. Scottish Government continues to engage regularly with key autism stakeholders including the National Autistic Society and Scottish Autism around our approach to managing COVID-19 and its associated harms .

All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers

The Stoma Care Quality and Cost Effectiveness Review, in 2016, and the National Stoma Quality Improvement Short Life Working Group (NSQIG), in 2019 recommended that NHS Boards who currently do not have an established Stoma Forum should consider this. The Scottish Government was not represented on the NSQIG and the recommendation was for NHS Boards to consider.

The Scottish Government does not hold this information and we expect individual NHS Boards to consider and implement this recommendation locally.

The first generic version of sapropterin has recently received a Marketing Authorisation from the Medicines and Healthcare products Regulatory Agency (MHRA). Healthcare Improvement Scotland are working to provide updated advice to Boards to enable routine prescribing of Sapropterin. We expect this to be in place in April. In the meantime, doctors can request access to medicines that are not generally available on the NHS on an individual case-by-case basis through local health board medicine governance processes.